Wed, February 3, 2016
Tue, February 2, 2016
Mon, February 1, 2016
Fri, January 29, 2016
Thu, January 28, 2016
Wed, January 27, 2016
Tue, January 26, 2016
Mon, January 25, 2016
Fri, January 22, 2016
Thu, January 21, 2016
Wed, January 20, 2016
Tue, January 19, 2016
Fri, January 15, 2016
Thu, January 14, 2016
Wed, January 13, 2016
Tue, January 12, 2016
Mon, January 11, 2016
Sun, January 10, 2016
Fri, January 8, 2016
Thu, January 7, 2016
Wed, January 6, 2016
Tue, January 5, 2016
Mon, January 4, 2016

Alethia Young Initiated (ALNY) at Buy and Held Target at $154 on, Jan 20th, 2016

  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. buy-and-held-target-at-154-on-jan-20th-2016.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Alethia Young of Credit Suisse, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Buy and Held Target at $154 on, Jan 20th, 2016.

Alethia has made no other calls on ALNY in the last 4 months.



There is 1 other peer that has a rating on ALNY. Out of the 1 peers that are also analyzing ALNY, 0 agree with Alethia's Rating of Hold.



This is the rating of the analyst that currently disagrees with Alethia


  • Paul Matteis of "Leerink Swann" Maintained at Buy with Increased Target to $152 on, Tuesday, November 10th, 2015